ArticleNature communications2026

Phenotype of circulating tumor-reactive T cells predicts immune checkpoint inhibitor response in non-small cell lung cancer.

Katsuhiro Ito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.